Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $75.33.
A number of equities research analysts have issued reports on NHI shares. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Bank of America initiated coverage on National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target for the company. Truist Financial reduced their target price on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating on the stock in a research note on Monday, December 23rd. Finally, Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price target for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st.
Read Our Latest Analysis on NHI
Institutional Investors Weigh In On National Health Investors
National Health Investors Trading Down 2.2 %
NHI stock opened at $66.22 on Tuesday. The firm has a market cap of $3.01 billion, a PE ratio of 22.76, a price-to-earnings-growth ratio of 4.86 and a beta of 1.06. The firm has a fifty day moving average price of $73.62 and a 200 day moving average price of $75.81. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors has a fifty-two week low of $51.59 and a fifty-two week high of $86.13.
National Health Investors (NYSE:NHI – Get Free Report) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same quarter last year, the firm earned $1.08 earnings per share. The business’s quarterly revenue was up 1.7% on a year-over-year basis. Sell-side analysts anticipate that National Health Investors will post 4.42 earnings per share for the current fiscal year.
National Health Investors Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 5.44%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s dividend payout ratio is presently 123.71%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
- Five stocks we like better than National Health Investors
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is the Shanghai Stock Exchange Composite Index?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- How to Plot Fibonacci Price Inflection Levels
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.